Sana Biotechnology, Inc.
SANA
DELAYED 1 MONTH

13 insider filings · Latest: Jun 4, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 5 8:43 PMPatrick Y YangDirector
Grant/Award
90,000$2.9690,000(D)

View →

Jun 4, 2026Jun 5 8:41 PMRobert L. RosielloDirector
Grant/Award
90,000$2.9690,000(D)

View →

Jun 4, 2026Jun 5 8:39 PMMichelle SeitzDirector
Grant/Award
90,000$2.9690,000(D)

View →

Jun 4, 2026Jun 5 8:38 PMAlise ReicinDirector
Grant/Award
90,000$2.9690,000(D)

View →

Jun 4, 2026Jun 5 8:36 PMRichard MulliganDirector
Grant/Award
90,000$2.9690,000(D)

View →

Jun 4, 2026Jun 5 8:34 PMHans Edgar BishopDirector
Grant/Award
90,000$2.9690,000(D)

View →

Jun 4, 2026Jun 5 8:32 PMJoshua H. BilenkerDirector
Grant/Award
90,000$2.9690,000(D)

View →

Jun 4, 2026Jun 5 8:25 PMRobert NelsenDirector, 10% Owner
Grant/Award
90,000$2.9690,000(D)

View →

Mar 7, 2026Mar 10 8:16 PMSteve HarrDirector, President & CEO
Option Exercise
50,000—100,000(D)

View →

Mar 6, 2026Mar 10 8:16 PMSteve HarrDirector, President & CEO
Option Exercise
41,666—125,001(D)

View →

Mar 7, 2026Mar 10 8:15 PMSusan D. WyrickSVP, Finance and Accounting and Principal Accounting Officer
Option Exercise
3,250—6,500(D)

View →

Mar 6, 2026Mar 10 8:15 PMSusan D. WyrickSVP, Finance and Accounting and Principal Accounting Officer
Option Exercise
10,416—31,251(D)

View →

Mar 5, 2026Mar 6 9:53 PMSusan D. WyrickSVP, Finance and Accounting and Principal Accounting Officer
Grant/Award
252,083$3.41206,250(D)

View →

Mar 5, 2026Mar 6 9:52 PMSteve HarrDirector, President & CEO
Grant/Award
1,100,000$3.41900,000(D)

View →

Mar 2, 2026Mar 4 9:17 PMSusan D. WyrickSVP, Finance and Accounting and Principal Accounting Officer
Option Exercise
1,525—1,525(D)

View →